202 related articles for article (PubMed ID: 29541430)
21. [Mortality risk factors in premature infants with respiratory distress syndrome treated by mechanical ventilation].
Fidanovski D; Milev V; Sajkovski A; Hristovski A; Sofijanova A; Kojić L; Kimovska M
Srp Arh Celok Lek; 2005; 133(1-2):29-35. PubMed ID: 16053172
[TBL] [Abstract][Full Text] [Related]
22. Early Inhaled Budesonide for the Prevention of Bronchopulmonary Dysplasia.
Bassler D; Plavka R; Shinwell ES; Hallman M; Jarreau PH; Carnielli V; Van den Anker JN; Meisner C; Engel C; Schwab M; Halliday HL; Poets CF;
N Engl J Med; 2015 Oct; 373(16):1497-506. PubMed ID: 26465983
[TBL] [Abstract][Full Text] [Related]
23. Continuous positive airway pressure (CPAP) for respiratory distress in preterm infants.
Ho JJ; Subramaniam P; Davis PG
Cochrane Database Syst Rev; 2020 Oct; 10(10):CD002271. PubMed ID: 33058208
[TBL] [Abstract][Full Text] [Related]
24. A multicenter randomized masked comparison trial of synthetic surfactant versus calf lung surfactant extract in the prevention of neonatal respiratory distress syndrome.
Hudak ML; Martin DJ; Egan EA; Matteson EJ; Cummings NJ; Jung AL; Kimberlin LV; Auten RL; Rosenberg AA; Asselin JM; Belcastro MR; Donohue PK; Hamm CR; Jansen RD; Brody AS; Riddlesberger MM; Montgomery P
Pediatrics; 1997 Jul; 100(1):39-50. PubMed ID: 9200358
[TBL] [Abstract][Full Text] [Related]
25. Less invasive surfactant administration versus endotracheal surfactant instillation followed by limited peak pressure ventilation in preterm infants with respiratory distress syndrome in China: study protocol for a randomized controlled trial.
Zhu J; Bao Y; Du L; Huang H; Lv Q; Jiang Y; Dai Y; Chen Z; Shi J; Shi Y; Yang C; Mei H; Jiang H; Sun Y; Sun X
Trials; 2020 Jun; 21(1):516. PubMed ID: 32527290
[TBL] [Abstract][Full Text] [Related]
26. Effects of less invasive surfactant administration versus intubation-surfactant-extubation on bronchopulmonary dysplasia in preterm infants with respiratory distress syndrome: a single-center, retrospective study from China.
Xu CC; Bao YY; Zhao JX; Cheng K; Sun L; Wu JY; Wu MY; Zhu JJ
BMC Pulm Med; 2022 Dec; 22(1):462. PubMed ID: 36471386
[TBL] [Abstract][Full Text] [Related]
27. Prophylactic synthetic surfactant for preventing morbidity and mortality in preterm infants.
Soll RF
Cochrane Database Syst Rev; 2000; (2):CD001079. PubMed ID: 10796410
[TBL] [Abstract][Full Text] [Related]
28. Continuous distending pressure for respiratory distress in preterm infants.
Ho JJ; Subramaniam P; Davis PG
Cochrane Database Syst Rev; 2015 Jul; 2015(7):CD002271. PubMed ID: 26141572
[TBL] [Abstract][Full Text] [Related]
29. A prospective randomized comparison of conventional mechanical ventilation and very early high frequency oscillatory ventilation in extremely premature newborns with respiratory distress syndrome.
Plavka R; Kopecký P; Sebron V; Svihovec P; Zlatohlávková B; Janus V
Intensive Care Med; 1999 Jan; 25(1):68-75. PubMed ID: 10051081
[TBL] [Abstract][Full Text] [Related]
30. Effectiveness of intratracheal salbutamol in addition to surfactant on the clinical course of newborns with respiratory distress syndrome: a clinical trial.
Dehdashtian M; Malakian A; Aramesh MR; Mazori A; Aletayeb MH; Shirani A; Bashirnejad S
Ital J Pediatr; 2016 Jan; 42():6. PubMed ID: 26786589
[TBL] [Abstract][Full Text] [Related]
31. Prophylactic natural surfactant extract for preventing morbidity and mortality in preterm infants.
Soll RF
Cochrane Database Syst Rev; 2000; 1997(2):CD000511. PubMed ID: 10796380
[TBL] [Abstract][Full Text] [Related]
32. Evaluation of intratracheal salbutamol effects in addition to surfactant in the clinical course of premature neonates with respiratory distress syndrome.
Goudarzi RM; Badiee Z; Sadeghnia A; Barekatain B
J Res Med Sci; 2023; 28():53. PubMed ID: 37496643
[TBL] [Abstract][Full Text] [Related]
33. Effects of antenatal indomethacin on ductus arteriosus early closure and on adverse outcomes in preterm neonates.
Doni D; Paterlini G; Locatelli A; Arnoldi S; Magri MC; Bernasconi D; Valsecchi MG; Tagliabue PE
J Matern Fetal Neonatal Med; 2020 Feb; 33(4):645-650. PubMed ID: 29986620
[No Abstract] [Full Text] [Related]
34. Multiple versus single doses of exogenous surfactant for the prevention or treatment of neonatal respiratory distress syndrome.
Soll R; Ozek E
Cochrane Database Syst Rev; 2009 Jan; (1):CD000141. PubMed ID: 19160177
[TBL] [Abstract][Full Text] [Related]
35. Early versus delayed selective surfactant treatment for neonatal respiratory distress syndrome.
Yost CC; Soll RF
Cochrane Database Syst Rev; 2000; (2):CD001456. PubMed ID: 10796266
[TBL] [Abstract][Full Text] [Related]
36. Intratracheal Administration of Budesonide/Surfactant to Prevent Bronchopulmonary Dysplasia.
Yeh TF; Chen CM; Wu SY; Husan Z; Li TC; Hsieh WS; Tsai CH; Lin HC
Am J Respir Crit Care Med; 2016 Jan; 193(1):86-95. PubMed ID: 26351971
[TBL] [Abstract][Full Text] [Related]
37. Intratracheal administration of budesonide with surfactant in very low birth weight infants to prevent bronchopulmonary dysplasia.
Heo M; Jeon GW
Turk J Pediatr; 2020; 62(4):551-559. PubMed ID: 32779407
[TBL] [Abstract][Full Text] [Related]
38. Animal derived surfactant extract for treatment of respiratory distress syndrome.
Seger N; Soll R
Cochrane Database Syst Rev; 2009 Apr; (2):CD007836. PubMed ID: 19370695
[TBL] [Abstract][Full Text] [Related]
39. Minimally invasive surfactant therapy versus InSurE in preterm neonates of 28 to 34 weeks with respiratory distress syndrome on non-invasive positive pressure ventilation-a randomized controlled trial.
Gupta BK; Saha AK; Mukherjee S; Saha B
Eur J Pediatr; 2020 Aug; 179(8):1287-1293. PubMed ID: 32462483
[TBL] [Abstract][Full Text] [Related]
40. Prophylactic versus selective use of surfactant in preventing morbidity and mortality in preterm infants.
Soll RF; Morley CJ
Cochrane Database Syst Rev; 2001; (2):CD000510. PubMed ID: 11405966
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]